Rejection of drug a blow for Australians living with Alzheimer’s disease
LISTEN TO PODCAST NOW
Podcast: Play in new window | Download (Duration: 9:45 — 13.4MB)
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS
A new treatment for people living with the early stages of Alzheimer’s disease or mild cognitive impairment has been rejected by the Therapeutic Goods Administration (TGA).
With Dementia becoming the leading cause of death in Australia, it’s disappointing news for those impacted by Alzheimers.
Guest: Dr Kaele Stokes is Dementia Australia’s Executive Director – Services, Advocacy & Research.
Presenter: Warren Andrew.
Podcast: Play in new window | Download (Duration: 9:45 — 13.4MB)
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS
RECENT PODCAST
Leo Stubbing: The Songs That Shaped 2025
From Kylie Minogue’s record-breaking Tension tour to Taylor Swift’s chart-dominating year, Leo Stubbing from The Sound Museum looks back on ...
LISTEN TO PODCAST NOW
Podcast: Play in new window | Download (Duration: 11:24 — 15.7MB)
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS
Associate Professor Lauren Rosewarne: Why Sad Christmas Songs Feel So Right
Many of the Christmas songs we return to each year are filled with heartbreak, nostalgia and longing. Associate Professor Lauren ...
LISTEN TO PODCAST NOW
Podcast: Play in new window | Download (Duration: 8:59 — 12.3MB)
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS
Kate Bailey: DIVA at the Australian Museum of Performing Arts
The Australian Museum of Performing Arts opens with DIVA, a major international exhibition created by London’s Victoria and Albert Museum. ...
LISTEN TO PODCAST NOW
Podcast: Play in new window | Download (Duration: 9:12 — 12.6MB)
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS